BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1
2583 results:

  • 1. The application of a single-hand-operated hepatic pedicle clamping clamp in laparoscopic hepatectomy.
    Shen Z; Jiang B; Chu H; Wang G; Fang X; Chen Z; Yang Y; Wang J; Wang X
    Langenbecks Arch Surg; 2024 Apr; 409(1):146. PubMed ID: 38691172
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Strategies to Perform Emergency Laparoscopic Partial liver Resection for Ruptured Hepatocellular Carcinoma.
    Tsunematsu M; Onda S; Shirai Y; Abe K; Horiuchi T; Haruki K; Furukawa K; Okui N; Taniai T; Ikegami T
    Anticancer Res; 2024 May; 44(5):2171-2176. PubMed ID: 38677754
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer.
    Zeng D; Yu C; Chen S; Zou L; Chen J; Xu L
    World J Surg Oncol; 2024 Apr; 22(1):93. PubMed ID: 38605359
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lifestyle factors, glycemic traits, and lipoprotein traits and risk of liver cancer: a Mendelian randomization analysis.
    Zhang H; Liu J
    Sci Rep; 2024 Apr; 14(1):8502. PubMed ID: 38605235
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Single extract of Forsythia Suspense versus the prepared drug in pieces: comparison of their anti-inflammatory, antitumor and antibacterial effects in zebrafish].
    Guo X; Guo Z; Sun D; Zou L; Ou J; Yu L; Lu Z; Cao H; Liu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):594-604. PubMed ID: 38597452
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Challenges in Diagnosis and Treatment of Male Hypogonadism.
    Purnamasari D
    Acta Med Indones; 2024 Jan; 56(1):1-2. PubMed ID: 38561883
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.
    Yarchoan M; Powderly JD; Bastos BR; Karasic TB; Crysler OV; Munster PN; McKean MA; Emens LA; Saenger YM; Ged Y; Stagg R; Smith S; Whiting CC; Moon A; Prasit P; Jenkins Y; Standifer N; Dubensky TW; Whiting SH; Ulahannan SV
    Cancer Res Commun; 2024 Apr; 4(4):1100-1110. PubMed ID: 38551394
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Combination of ethyl acetate fraction from Calotropis gigantea stem bark and sorafenib induces apoptosis in HepG2 cells.
    Chaisupasakul P; Pekthong D; Wangteeraprasert A; Kaewkong W; Somran J; Kaewpaeng N; Parhira S; Srisawang P
    PLoS One; 2024; 19(3):e0300051. PubMed ID: 38527038
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Salivary gland adenoid cystic carcinoma in the U.S population: Importance of grade, site of metastases, and adjuvant radiation for survival.
    Ullah A; Ahmed A; Lee KT; Yasinzai AQK; Lewis JS
    Am J Otolaryngol; 2024; 45(3):104266. PubMed ID: 38522261
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [cancer incidence and mortality in China, 2022].
    Zheng RS; Chen R; Han BF; Wang SM; Li L; Sun KX; Zeng HM; Wei WW; He J
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):221-231. PubMed ID: 38468501
    [No Abstract]    [Full Text] [Related]  

  • 11. Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with tyrosine kinase inhibitors (TKIs) in patients with unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis.
    Ji J; Zhang Z; Hou Z; Qiu G; Mi S; Jin Z; Huang J
    Clin Res Hepatol Gastroenterol; 2024 Apr; 48(4):102313. PubMed ID: 38453011
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Optimizing lifestyle profiles is potential for preventing nonalcoholic fatty liver disease and enhancing its survival.
    Tu B; Li W; Xiao H; Xu X; Zhang Y
    Sci Rep; 2024 Mar; 14(1):5516. PubMed ID: 38448563
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Chemoembolization as first-line treatment for hepatocellular carcinoma invading segmental portal vein with tumour burden limited to a monosegmental level.
    Hwang H; Kim JH; Ko E; Kim JY; Ko HK; Gwon DI; Shin JH; Kim GH; Chu HH
    Br J Radiol; 2024 May; 97(1157):1038-1043. PubMed ID: 38445658
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
    Piscitelli J; Reddy MB; Wollenberg L; Del Frari L; Gong J; Wood L; Zhang Y; Matschke K; Williams JH
    Clin Pharmacokinet; 2024 Apr; 63(4):483-496. PubMed ID: 38424308
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
    Yau T; Kaseb A; Cheng AL; Qin S; Zhu AX; Chan SL; Melkadze T; Sukeepaisarnjaroen W; Breder V; Verset G; Gane E; Borbath I; Rangel JDG; Ryoo BY; Makharadze T; Merle P; Benzaghou F; Milwee S; Wang Z; Curran D; Kelley RK; Rimassa L
    Lancet Gastroenterol Hepatol; 2024 Apr; 9(4):310-322. PubMed ID: 38364832
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA-II), serum a-fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non-diagnostic serum a-fetoprotein levels.
    Syriha A; Pantzios S; Mandilara D; Galanis P; Stathopoulou I; Barla G; Elefsiniotis I
    Cancer Med; 2024 Feb; 13(3):e6825. PubMed ID: 38361401
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Adherence and impact of an oral nutritional supplement enriched in leucine, EVOO, EPA and DHA, and beta-glucans on the coverage of energy and protein requirements in patients with cancer and malnutrition: Alisenoc study.
    Milla SP; Luna PPG; Casariego AV; González FV; Folgueras TM; Jáuregui OI; Rey SG; Fernández AC; Plaza BL; Quintana TC; de Luis Román DA
    Nutrition; 2024 Apr; 120():112355. PubMed ID: 38341907
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma.
    Huang K; He Y; Liang T; Mo S; Liao Y; Gao Q; Liao X; Han C; Zhu G; Peng T
    Sci Rep; 2024 Feb; 14(1):3314. PubMed ID: 38332165
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Left Hepatectomy Combined with Right Hepatic Artery Resection and Reconstruction for Hilar Cholangiocarcinoma.
    Zhang J; Xu B; Chen W; Huang K; Lan Z; Zhu H; Wang J; Zhang L; Lu T; Guo Y; Wen Z
    Ann Surg Oncol; 2024 May; 31(5):3086. PubMed ID: 38319517
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Achieving 400 Living Donor liver Transplantations Annually During the COVID-19 Pandemic: A Single-Center Experience.
    Kim SM; Yoon YI; Moon DB; Kim KH; Ahn CS; Ha TY; Song GW; Jung DH; Park GC; Kang WH; Cho HD; Jwa E; Ha SM; Na BG; Kim MJ; Kim SH; Yang G; Oh RK; Hwang S; Lee SG
    Transplant Proc; 2024; 56(1):116-124. PubMed ID: 38302403
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 130.